- ►nih.gov - Free from Publisher A Ang, MA Reddy, L Shepstone, DC … - British Journal of Ophthalmology, 2004 - bjo.bmj.com Results: 76 newly diagnosed patients with NTG were recruited—26 had fixation
threatening disease, 25 were randomised to treatment, and 25 randomised to the
control group. The average duration of treatment was 11 months. The average ... Cited by 18 - Related articles - BL Direct - All 9 versions
G Tomita, M Araie, Y Kitazawa, S Tsukahara - Eye, 2004 - nature.com Patients and methods This is an open-label, randomized, study. A total of 62 NTG
patients were prospectively, consecutively enrolled. All study subjects were
randomly assigned to 0.005% latanoprost instillation once daily in the ... Cited by 13 - Related articles - BL Direct - All 3 versions
EL Greve, AH Rulo, SM Drance, AC Crichton, … - Survey of ophthalmology, 1997 - Elsevier Currently used ocular hypotensive agents do not effectively lower intraocular
pressure (IOP) in some normal-tension glaucoma (NTG) patients. The prostaglandin
F 2α analogue, latanoprost, has been shown to reduce IOP in normal ... Cited by 25 - Related articles - BL Direct - All 4 versions
SA Gandolfi, L Rossetti, L Cimino, P Mora, M … - Journal of Glaucoma, 2003 - journals.lww.com Cited Here...: One hundred thirty-six eyes (68 eyes/treatment group) were
randomized according to intraocular pressure level and the number of adjunctive
medications to beta blocker. Both treatments provided a significant IOP ... Cited by 5 - Related articles - BL Direct - All 2 versions
Y Tamada, T Taniguchi, H Murase, T … - Journal of Ocular Pharmacology and Therapeutics, 2001 - liebertonline.com We investigated the intraocular pressure (IOP)-lowering potential of latanoprost
in patients with normal-tension glaucoma (NTG) or primary open-angle glaucoma
(POAG). This prospective study included 59 NTG and 20 POAG patients treated ... Cited by 15 - Related articles - BL Direct - All 5 versions
PFJ Hoyng, Y Kitazawa - Survey of ophthalmology, 2002 - Elsevier Normal-tension glaucoma was previously thought to be pressure insensitive, as
medical treatment hardly reduced intraocular pressure and it did not prevent
visual field loss. In the last decade, however, evidence has shown that the ... Cited by 27 - Related articles - All 13 versions
M McKibbin, MJ Menage - Eye, 1999 - grande.nal.usda.gov Record Detail. Return to previous page, Save: Title: The effect of once-daily
latanoprost on intraocular pressure and pulsatile ocular ... Cited by 50 - Related articles - Cached - BL Direct - All 3 versions
AH Rulo, EL Greve, HC Geijssen, PF Hoyng - Ophthalmology, 1996 - ncbi.nlm.nih.gov PURPOSE: Currently available ocular hypotensive agents often fail to lower
intraocular pressure (IOP) in patients with normal-pressure glaucoma (NPG). The
authors evaluated the IOP-reducing potential and side effects of ... Cited by 62 - Related articles - BL Direct - All 6 versions
